Therapeutic Area Lead Oncology/Hematology/PAH, Janssen
Medical Degree, Specialty, MSc, PhD
Medical Degree from Athens University School of Medicine
(“Very Good”, 1990-1997).
Internal Medicine Specialty, 3rd Department of Internal Medicine, Athens
University School of Medicine, “Sotiria” Hospital (2001-2007, certified June 2007).
Master of Science (M.Sc): Master in Thoracic Oncology
Two years Educational Post Graduate Program: 3rd Department of Internal Medicine, Oncology Unit, University of Athens.
Ph.D thesis – Oncology
Ethnikon kai Kapodistriakon University of Athens Medical School: “Measurements of 8 – isoprostane in exhaled breath condensate and serum of patients with non small cell lung cancer (NSCLC), before and after chemotherapy. Correlation with clinical and pathological parameters”,
Grade: “Excellent”
WORK EXPERIENCE ( PHARMA )
3/2021 – today : Therapeutic Area Lead Oncology/Hematology/PAH – Janssen
01/2011 – 2/2021: Senior Scientific Advisor Oncology – Bristol Myers Squibb
Senior Scientific Advisor for Hematology ( 2011 – 2012, dasatinib for CML ) , Oncology ( 2011 – today with focus on Immuno Oncology for nivolumab plus ipilimumab in thoracic portfolio plus GI portfolio) and CV ( 2014 – 2015, apixaban – anticoagulant indication , “Alliance” with Pfizer )
Responsible for Team Alignment of Greek Oncology Medical Team (2 Scientific Advisors and 2 Medical Liaisons) regarding: on boarding of new members, training on internal processes / SOPs ,coaching and guidance on annual objectives , strategy alignment, KOLs management, budget planning, allocation and execution.
People Management – manager of the MSLs (2) as direct reports
Lead CEETII Regional Thoracic indications Network (Coordinate and act as Lead for Scientific Advisors for thoracic portfolio for CEETII BMS Region)
Represent company to Greek Board of Medical Directors of Hellenic Association of Pharmaceutical Companies (SFEE)
Current responsibilities:
Plan and execution of annual Medical Plan
Plan, phasing and execution of Medical budget
Owner and Trainer of company’s Non-Promotional materials, SOPs and directives
Collaboration and adherence to internal processes and procedures in the aim of full compliance for the non-promotional activities
Medical review of non-promotional and promotional materials
Field scientific support: training of SF and Clinical Operations Team
Plan, organize and execution of Local and Regional Medical events (Ad Boards, standalone events and non – promotional Events, satellite symposia, medical info booths, Regional preceptorship programs)
Clinical Studies medical support and coordination (site selection, site feasibility, country position, follow up in clinical trials, liaise with CRO for outsourced trials)
Key member of Brand meeting and cross functional team establishing collaboration with: marketing, sales, access, finance, regulatory and legal departments.
Deliver scientific internal presentations to cross functional team for alignment.
Extensive High level customer facing, KOLs management and development
Established external relationships with local and international Key Opinion Leaders
Medical support to foreign markets (Cyprus) / Alliance experience (apixaban, co –marketing with Pfizer)
Accomplishments/ Projects
Responsible for the Pre – Launch and Post – Launch medical activities for both ipilimumab and nivolumab in different indications characterized as “best in class” within innovative cancer drugs
Reconciliation of the Educational material (Curriculum) database for ipilimumab in European Market
Patient Support Programs: Implementation and execution of the Compassionate Use Program for ipilimumab in Greece (participation of > 60 melanoma patients)
Patient Support Programs: Implementation and execution of Named Patient Program for nivolumab in NSCLC (participation of >150 patients)
Awarded (2019) for 2 Innovative projects in Global/Worldwide level as 1st and 2nd place: I O Portal and eligible subpopulations for expanding I O 2nd line NSCLC project
Act as mentor and trainer in I O for BMS India: train India Medical Team by regular TCs for 3 months period / Plan and execute F2F training to India for lung and renal cancer indications
Leader of Innovative project: Idea owner, implementation and execution of the “Medical Access I O Roadshow” for Greece and Cyprus by incorporating medical and access value data in the same presentation, customized to different external stakeholders (physicians , payers, Health Authorities ) – awarded as among 10 Top Medical Projects from Global Medical Team
Leader of Innovative project: Increase awareness and educate in Immuno – Oncology the Key anticancer Advocacy Groups in Greece and Cyprus in collaboration with access and patient advocacy manager, by delivering relative presentations and driving effective discussions
Leader of Innovative project: Implementation and execution of the “Abatacept e database project” : Creation and use of company’s e Data Bank with the form of an e – File (Acrobat Reader) available to ipads , which included all Key documents for the specific product, practical for everyday interactions with external customers
Leader of Innovative project: Idea, implementation and execution of the “I O – Building the Network among specialties” – Series of Non promotional Events, with the scope to best evaluate the management of irAEs for Immunotherapy as a new treatment modality
Established cross-functional collaboration with market access team for preparing the value dossier for I O drugs for submission to Health Authorities (EOF) in regards to reimbursement and price negotiation purposes
Deliver all key company’s presentations regarding pipeline and I O portfolio to Key Oncology Hospitals, National Oncology Congresses and in collaboration with access department to Health Authorities (EOF – EOPYY), Hospital Committees
Plan, organize and execute Regional Preceptorship programs (non promotional – educational Events) for lung cancer indication, characterized as best practice within CEEME BMS Region
Participation in “patient centric programs” at Hellenic Association of Pharmaceutical Companies (SFEE) subcommittee
05/2009 – 12/2010: Medical Manager/Oncology – Roche Greece
Responsible for scientific – Medical support for Oncology products: bevacizumab – erlotinib in Lung Cancer indication
Accomplishments / Projects
Avastin (bevacizumab) Lung Team/Greece was recognized as the one with the highest penetration in Lung cancer indication throughout Europe (2010)
Participation to the reconciliation/update procedure of Roche Clinical Trials Roadmap through cross functional team work.
CLINICAL EXPERIENCE
- 07/2007- 05/2009: Scientific Associate as specialized Internist in the Oncology Unit of the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases, Athens
- 10/2005 – 04/2007: Resident in Internal Medicine as Associate of the Oncology Unit in the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
- 07/2005 -10/2005: Resident in Internal Medicine in the Intensive Care Unit of Sotiria General Hospital of Chest Diseases, Athens
- 04/2005 – 07/2005: Resident in Internal Medicine in the Cardiology Clinic of Sotiria General Hospital of Chest Diseases, Athens
- 06/2004 – 06/2005: Associate of the External Rheumatology Unit during Residency in Internal Medicine in the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
- 04/2004 – 04/2005: Resident in Internal Medicine in the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
- 09/2002- 09/2003: Resident in Internal Medicine in the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
- 09/2001-09/2002: Resident in Internal Medicine in the Respiratory Failure Centre (ΚΑΑ) , Sotiria General Hospital of Chest Diseases
- 01/2001-07/2001: Resident in Internal Medicine in the 2nd Internal Medicine Clinic of the 251 Air Force General Hospital ( Hematology – Oncology Clinic)
- 10/1997-10/1999: Rural Service Doctor in the Health Center of Megalopolis ,Arcadia
LANGUAGES
English: PROFICIENCY (University of Michigan)
COMPUTER KNOWLEDGE
- Excellent knowledge of PC in MS-Windows environment (Word – Excel – Access – Power Point)
- Excellent knowledge of Internet use and e-mail (MS Explorer, MS Outlook & Outlook Express)
- Knowledge of statistical packages (SPSS for Windows)
MILITARY OBLIGATIONS COMPLETED
Military Air Force: November 1999 – July 2001 with the following participation:
- Assistant Doctor in Cardiology Clinic, 251 General Air Force Hospital (12/1999 – 3/2000)
- Assistant Doctor in Hematology – Oncology Clinic, 251 General Air Force Hospital (1/2001 – 7/2001)
TEACHING EXPERIENCE
- Academic Year 2008 – 2009: Trainer in Internal Medicine of undergraduate students ( 4th year) of the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
- Academic Year 2007 – 2008: Trainer in Internal Medicine of undergraduate students ( 4th year) of the 3rd Department of Medicine, Athens University School of Medicine, Sotiria General Hospital of Chest Diseases
CHAIRMAN / SPEAKER DURING ONCOLOGY CONGRESSES
- Speaker on behalf of BMS in numerous Local Oncology congresses with focus on: Oncology, pipeline, Immuno Oncology
- LECTURE:Challenges for designing clinical trials today Chairs:A. Korogiannos D. Stathopoulos Speaker: L. Pilz, 5th Symposium «Lung cancer: From diagnosis to treatment»,09/2018
- LECTURE: Clinical trials in lung cancer – 2017. Consideration for precision medicine Chair: Manegold, D. Stathopoulos 4th Symposium «Lung cancer: From diagnosis to treatment», 09/2017
- ΣΤΡΟΓΓΥΛΟ ΤΡΑΠΕΖΙ: Υγρή βιοψία. Τεχνικές ανάλυσης και κλινικής σημασία. Τελευταίες εξελίξεις Προεδρείο: Δ. Σταθόπουλος, Α. Σομαράκης, 4o FORUM, ΒΙΟΕΠΙΣΤΗΜΕΣ & ΚΑΡΚΙΝΟΣ, 10/2017
- ΔΙΑΛΕΞΗ: Πως στήνεται μια start up επιχείρηση βιοτεχνολογίας, Προεδρείο: Δ. Σταθόπουλος, Α. Γιαμάς, Εισηγητής: Δ. Καλαβρός , 3ο FORUM, ΒΙΟΕΠΙΣΤΗΜΕΣ ΚΑΙ ΚΑΡΚΙΝΟΣ, 10/2015
ANNOUNCEMENTS – CONGRESS LECTURES – PAPERS
- Stathopoulos, S. Loukides and K. Syrigos, “8-Isoprostane in Exhaled Breath Condensate of Patients with Non-small Cell Lung Cancer: The Effect of Chemotherapy”, ANTICANCER RESEARCH 34: 5143-5146 (2014)
- Δ.Σταθόπουλος: Ομιλία με τίτλο « Διάρροια και Δυσκοιλιότητα στον Ογκολογικό Ασθενή», ως Διδάσκων στους Νέους Ογκολόγους, ΕΑΚΟ 2009 – Θεματολογία: Υποστηρικτική Αγωγή, Ογκολογία Τρίτης Ηλικίας, Ιωνικό Κέντρο 12 – 14/6/2009, Πλάκα, Αθήνα
- Σ. Παπαδόπουλος, Δ. Σταθόπουλος, Ι. Γκιόζος: « Η Αναιμία της Χρονίας Νόσου σε καρκινοπαθείς με συμπαγή όγκο». 2ο Συνέδριο Ογκολογίας στην Πρωτοβάθμια Περίθαλψη, Αθήνα 5-6 Δεκεμβρίου 2008. Εκπαιδευτικός Τόμος: σελ 48-53
- Σ. Πέππα, Δ. Σταθόπουλος: « Μεγαλοβλαστική Αναιμία σε ασθενείς με νεοπλασματικά νοσήματα». 2ο Συνέδριο Ογκολογίας στην Πρωτοβάθμια Περίθαλψη, Αθήνα 5-6 Δεκεμβρίου 2008. Εκπαιδευτικός Τόμος: σελ 26-36
- Π. Πετεινάτος, Δ. Σταθόπουλος: « Σιδηροπενική Αναιμία σε ασθενείς με νεοπλασματικά νοσήματα». 2ο Συνέδριο Ογκολογίας στην Πρωτοβάθμια Περίθαλψη, Αθήνα 5-6 Δεκεμβρίου 2008. Εκπαιδευτικός Τόμος: σελ 13-25
- Δ. Σταθόπουλος. «Ψυχολογική – Κοινωνική Προσέγγιση του Ογκολογικού Ασθενή – Internet: Πως ωφελείται ο Επαγγελματίας Υγείας». Ομιλία σε Ημερίδα Νοσηλευτικής Ογκολογίας, Αθήνα 22 Νοεμβρίου 2008
- Δ. Σταθόπουλος. «Πληροφορίες στο Διαδίκτυο: Ποιος Κερδίζει;».Ομιλία στο 9ο Πανελλήνιο Συνέδριο Ακτινοθεραπευτικής Ογκολογίας, Thraki Palace, Αλεξανδρούπολη 19 – 22 Ιουνίου 2008. Βιβλίο Περιλήψεων, σελ: 55 – 57
- Δ. Σταθόπουλος «Συμπτώματα από το πεπτικό σύστημα σε ασθενείς με νεοπλασματικά νοσήματα, Αίτια και Αντιμετώπιση: Δυσκοιλιότητα». Ομιλία στο 1ο Συνέδριο Ογκολογίας στην Πρωτοβάθμια Περίθαλψη. Αθήνα 2-3 Νοεμβρίου 2007
- Giozos, N. Katirtzoglou, K. Pantazopoulos, D. Stathopoulos, I. Tzanou, E. Chondrou, A. Zalonis, E. Katirtzoglou, K. Giannopoulos, k.Syrigos. « Biweekly carboplatin – gemcitabine in Elderly patients with advanced NSCLC. A phase II study». European Respiratory Journal. Abstracts 17th ERS Annual Congress. Stockholm, Sweden, September 15 – 19, 2007, Poster No: P2556
TRAININGS / SEMINARS
- July 2009 – now: participation in a large number of seminars/ trainings for development of personal skills: Management Essentials (Harvard School course ) , People management programs, Matrix Leadership skills, time management, stress management, advanced presentation and communication skills, basic and advanced principles of Health Economics, coaching and mentoring , project management, Medical Marketing for medical managers, GCP training, Introduction to Clinical Research, etc